MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients

C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India

C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India

Organon introduces global ESG strategy

Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health

Fortis Healthcare opens Healthcare Information Centre at Tirupati

The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.

Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital

The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

PMBI first time ever crossed Rs. 100 crore sales in May, 2022

Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children

Mezzion Pharma receives clear FDA path forward for the approval of Udenafil for single ventricle heart disease